Comparative effects of raw and processed cistanche glycosides on the HPT axis and gut microbiota in a rat model of kidney-yang deficiency
This integrative approach of gut microbiome and fecal metabolomics not only provides a scientific basis for CDG's preventive effects on KYD via the HPT axis but also elucidates the potential mechanisms underlying CDG's action against KYD.
Authors
- Ji Shi (ORCID: https://orcid.org/0000-0002-6409-4662)
- Nan Xu (ORCID: https://orcid.org/0009-0007-0218-5319)
- Yuan Zhang (ORCID: https://orcid.org/0000-0002-0127-7736)
- Chao Zhang (ORCID: https://orcid.org/0000-0001-6418-8370)
- Xiao‐Qing Shen
- Jing Lian (ORCID: https://orcid.org/0000-0003-4828-2740)
- Jia Tian-zhu (ORCID: https://orcid.org/0000-0002-6529-4025)
- Yixiang Miu
Institutions
- State Administration of Traditional Chinese Medicine of the People's Republic of China (CN)
- Liaoning University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-07-25
- DOI
- https://doi.org/10.3389/fphar.2025.1597564
- Citations
- 3
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 2.42
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Liaoning Province